• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Unclear if medical therapy management improves health outcomes

byShayna BejaimalandJames Jiang
November 18, 2014
in Chronic Disease, Public Health
Reading Time: 3 mins read
Unclear if medical therapy management improves health outcomes
Share on FacebookShare on Twitter

1. There is insufficient evidence to make conclusions on the effects of medical therapy management (MTM) programs on mortality, morbidity and adverse drug events.

2. There is low-strength evidence for MTM intervention improving medication adherence, health care expenditures and risk of hospitalizations of patients with diabetes and heart failure.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Medications, while foundational to patient care, also provide an opportunity for adverse events. They may be wrongly prescribed, patients may be non-adherent or they may be inadequately dosed. Medical therapy management (MTM) programs provide a strategy to deliver services to patients and clinicians to help decrease the occurrence of these adverse events. However, the efficacy of these programs on health care outcomes is unknown. This systematic review aimed to assess the risks and benefits of outpatient-based MTM programs when compared to usual care in patients with chronic illnesses. Particularly, this study looked at medication-related problems, morbidity, mortality, quality of life, health care use, costs and harms.

There was insufficient evidence to draw conclusions on a majority of the a priori determined health care outcomes. The interventions did show some improvement in medication appropriateness, medical adherence, health plan expenditures on medications and risk of hospitalizations in patients with diabetes and heart failure, but did not show improvement in measures of quality of life outcomes, and patent satisfaction. However, due to high heterogeneity among interventions and study populations and medium to high risk of bias among all studies, the evidence strength for these results is low. Strengths of this study include being a thorough systematic review on the evidence of MTM program use, as well as examining a large number of patient centered outcomes. However, decreased study quality and intervention and population variability resulted in an inability to pool results and thus limits the applicability of this review’s findings.

Click to read the study, published today in JAMA Internal Medicine

RELATED REPORTS

Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals

Intensive multifaceted management may improve blood pressure control among low-income patients

Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy

Relevant Reading: Medication therapy management: its relationship to patient counselling, disease management, and pharmaceutical care

In-Depth [systematic review and meta-analysis]: This systematic review and meta analysis examined all MTM-related randomized controlled trials (RCTs), nonrandomized clinical trials (NRCT), cohort studies and case-control studies in MEDLINE, Cochrane Library and the International Pharmaceutical Abstracts database from inception to January 2014. Quality of studies was assessed and studies were rated as low, medium, high, or unclear risk of bias. Of 2,516 articles found, 61 articles (representing 44 studies) met inclusion criteria: 21 RCTs, 4 NRCTs, and 19 cohort studies. Six of these studies were included in the meta-analyses. The majority of these studies were rated as having medium or high risk of bias. Results were unable to be pooled due to this high level of bias and heterogeneity.

There was a 4.6% improvement in medication adherence, and improvement in medication appropriateness (4.9 vs 0.9 points on a medication appropriateness index, p<0.001). For patients with diabetes and heart failure there was a decrease in risk of hospitalizations (OR 0.9, 95%CI 0.91-0.93 and HR 0.55, 95%CI 0.39-0.77, respectively). The meta-analysis included 4 low bias studies and showed non-significant impact of MTM programs on overall mean number of outpatient visits and overall mean number of hospitalizations.

More from this author: Overall US diet quality improved from 1999 to 2010, Arterial catheter monitoring in ICU not associated with mortality benefit, Effectiveness of medical device postapproval surveillance unclear, Inconsistent quality of evidence for biomarker use on FDA drug labels, Maintenance opioids in drug users linked with lower rate of hepatitis C infection

Image: Wiki/GNU Free

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: medication adherence
Previous Post

Hyperbaric oxygen does not significantly improve post-concussion symptoms

Next Post

NSAIDs linked with serious bleeding in afib patients

RelatedReports

Quick Take: Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial
All Specialties

Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals

May 13, 2026
Preeclampsia linked to autism and developmental delay
Cardiology

Intensive multifaceted management may improve blood pressure control among low-income patients

April 9, 2026
Primary care physicians play substantial role in pediatric mental health
Cardiology

Adults with attention-deficit/hyperactivity disorder are at higher risk of poor long-term adherence to antihypertensive therapy

February 27, 2026
Cardiology

Depression may be associated with reduced adherence to direct-acting oral anticoagulants in atrial fibrillation patients

November 27, 2023
Next Post
NSAIDs linked with serious bleeding in afib patients

NSAIDs linked with serious bleeding in afib patients

Smoking linked to increased risk of chronic dysmenorrhea

Smoking linked to increased risk of chronic dysmenorrhea

Increased infections noted with longer duration neonatal PICC placement

Novel system rapidly detects low levels of bacteria in blood [PreClinical]

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Historical redlining associated with lower breast cancer screening across urban neighborhoods
  • N-methylaniline exposure identified as likely cause of methemoglobinemia during maritime migration
  • Video mental health care may have clinical advantages versus phone or in-person visits
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.